
|Articles|September 20, 2011
Positive Phase II study results announced
Novagali Pharma has announced positive results from its Phase II trial of the preservative-free cationic emulsion, Catioprost.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
















































